Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Targeted Biomarker Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Targeted Biomarker Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Targeted Biomarker Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Safety biomarker
    • 1.4.3 Efficacy biomarker
    • 1.4.4 Validation biomarker
  • 1.5 Market by Application
    • 1.5.1 Global Targeted Biomarker Market Share by Application: 2020 VS 2026
    • 1.5.2 Diagnostics development
    • 1.5.3 Drug discovery & development
    • 1.5.4 Personalized medicine
    • 1.5.5 Disease risk assessment
    • 1.5.6 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Targeted Biomarker Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Targeted Biomarker Industry
      • 1.6.1.1 Targeted Biomarker Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Targeted Biomarker Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Targeted Biomarker Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Targeted Biomarker Market Perspective (2015-2026)
  • 2.2 Targeted Biomarker Growth Trends by Regions
    • 2.2.1 Targeted Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Targeted Biomarker Historic Market Share by Regions (2015-2020)
    • 2.2.3 Targeted Biomarker Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Targeted Biomarker Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Targeted Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Targeted Biomarker Players by Market Size
    • 3.1.1 Global Top Targeted Biomarker Players by Revenue (2015-2020)
    • 3.1.2 Global Targeted Biomarker Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Targeted Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Targeted Biomarker Market Concentration Ratio
    • 3.2.1 Global Targeted Biomarker Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Targeted Biomarker Revenue in 2019
  • 3.3 Targeted Biomarker Key Players Head office and Area Served
  • 3.4 Key Players Targeted Biomarker Product Solution and Service
  • 3.5 Date of Enter into Targeted Biomarker Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Targeted Biomarker Historic Market Size by Type (2015-2020)
  • 4.2 Global Targeted Biomarker Forecasted Market Size by Type (2021-2026)

5 Targeted Biomarker Breakdown Data by Application (2015-2026)

  • 5.1 Global Targeted Biomarker Market Size by Application (2015-2020)
  • 5.2 Global Targeted Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Targeted Biomarker Market Size (2015-2020)
  • 6.2 Targeted Biomarker Key Players in North America (2019-2020)
  • 6.3 North America Targeted Biomarker Market Size by Type (2015-2020)
  • 6.4 North America Targeted Biomarker Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Targeted Biomarker Market Size (2015-2020)
  • 7.2 Targeted Biomarker Key Players in Europe (2019-2020)
  • 7.3 Europe Targeted Biomarker Market Size by Type (2015-2020)
  • 7.4 Europe Targeted Biomarker Market Size by Application (2015-2020)

8 China

  • 8.1 China Targeted Biomarker Market Size (2015-2020)
  • 8.2 Targeted Biomarker Key Players in China (2019-2020)
  • 8.3 China Targeted Biomarker Market Size by Type (2015-2020)
  • 8.4 China Targeted Biomarker Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Targeted Biomarker Market Size (2015-2020)
  • 9.2 Targeted Biomarker Key Players in Japan (2019-2020)
  • 9.3 Japan Targeted Biomarker Market Size by Type (2015-2020)
  • 9.4 Japan Targeted Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Targeted Biomarker Market Size (2015-2020)
  • 10.2 Targeted Biomarker Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Targeted Biomarker Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Targeted Biomarker Market Size by Application (2015-2020)

11 India

  • 11.1 India Targeted Biomarker Market Size (2015-2020)
  • 11.2 Targeted Biomarker Key Players in India (2019-2020)
  • 11.3 India Targeted Biomarker Market Size by Type (2015-2020)
  • 11.4 India Targeted Biomarker Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Targeted Biomarker Market Size (2015-2020)
  • 12.2 Targeted Biomarker Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Targeted Biomarker Market Size by Type (2015-2020)
  • 12.4 Central & South America Targeted Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 bioMerieux
    • 13.1.1 bioMerieux Company Details
    • 13.1.2 bioMerieux Business Overview and Its Total Revenue
    • 13.1.3 bioMerieux Targeted Biomarker Introduction
    • 13.1.4 bioMerieux Revenue in Targeted Biomarker Business (2015-2020))
    • 13.1.5 bioMerieux Recent Development
  • 13.2 IntegraGen
    • 13.2.1 IntegraGen Company Details
    • 13.2.2 IntegraGen Business Overview and Its Total Revenue
    • 13.2.3 IntegraGen Targeted Biomarker Introduction
    • 13.2.4 IntegraGen Revenue in Targeted Biomarker Business (2015-2020)
    • 13.2.5 IntegraGen Recent Development
  • 13.3 Myriad Genetics
    • 13.3.1 Myriad Genetics Company Details
    • 13.3.2 Myriad Genetics Business Overview and Its Total Revenue
    • 13.3.3 Myriad Genetics Targeted Biomarker Introduction
    • 13.3.4 Myriad Genetics Revenue in Targeted Biomarker Business (2015-2020)
    • 13.3.5 Myriad Genetics Recent Development
  • 13.4 Protagen
    • 13.4.1 Protagen Company Details
    • 13.4.2 Protagen Business Overview and Its Total Revenue
    • 13.4.3 Protagen Targeted Biomarker Introduction
    • 13.4.4 Protagen Revenue in Targeted Biomarker Business (2015-2020)
    • 13.4.5 Protagen Recent Development
  • 13.5 Qiagen
    • 13.5.1 Qiagen Company Details
    • 13.5.2 Qiagen Business Overview and Its Total Revenue
    • 13.5.3 Qiagen Targeted Biomarker Introduction
    • 13.5.4 Qiagen Revenue in Targeted Biomarker Business (2015-2020)
    • 13.5.5 Qiagen Recent Development
  • 13.6 PerkinElmer
    • 13.6.1 PerkinElmer Company Details
    • 13.6.2 PerkinElmer Business Overview and Its Total Revenue
    • 13.6.3 PerkinElmer Targeted Biomarker Introduction
    • 13.6.4 PerkinElmer Revenue in Targeted Biomarker Business (2015-2020)
    • 13.6.5 PerkinElmer Recent Development
  • 13.7 Merck Millipore
    • 13.7.1 Merck Millipore Company Details
    • 13.7.2 Merck Millipore Business Overview and Its Total Revenue
    • 13.7.3 Merck Millipore Targeted Biomarker Introduction
    • 13.7.4 Merck Millipore Revenue in Targeted Biomarker Business (2015-2020)
    • 13.7.5 Merck Millipore Recent Development
  • 13.8 Bio-Rad Laboratories
    • 13.8.1 Bio-Rad Laboratories Company Details
    • 13.8.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
    • 13.8.3 Bio-Rad Laboratories Targeted Biomarker Introduction
    • 13.8.4 Bio-Rad Laboratories Revenue in Targeted Biomarker Business (2015-2020)
    • 13.8.5 Bio-Rad Laboratories Recent Development
  • 13.9 Enzo Biochem
    • 13.9.1 Enzo Biochem Company Details
    • 13.9.2 Enzo Biochem Business Overview and Its Total Revenue
    • 13.9.3 Enzo Biochem Targeted Biomarker Introduction
    • 13.9.4 Enzo Biochem Revenue in Targeted Biomarker Business (2015-2020)
    • 13.9.5 Enzo Biochem Recent Development
  • 13.10 EKF Diagnostics
    • 13.10.1 EKF Diagnostics Company Details
    • 13.10.2 EKF Diagnostics Business Overview and Its Total Revenue
    • 13.10.3 EKF Diagnostics Targeted Biomarker Introduction
    • 13.10.4 EKF Diagnostics Revenue in Targeted Biomarker Business (2015-2020)
    • 13.10.5 EKF Diagnostics Recent Development
  • 13.11 Meso Scale Diagnostics, LLC.
    • 10.11.1 Meso Scale Diagnostics, LLC. Company Details
    • 10.11.2 Meso Scale Diagnostics, LLC. Business Overview and Its Total Revenue
    • 10.11.3 Meso Scale Diagnostics, LLC. Targeted Biomarker Introduction
    • 10.11.4 Meso Scale Diagnostics, LLC. Revenue in Targeted Biomarker Business (2015-2020)
    • 10.11.5 Meso Scale Diagnostics, LLC. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Targeted Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Targeted Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    bioMerieux
    IntegraGen
    Myriad Genetics
    Protagen
    Qiagen
    PerkinElmer
    Merck Millipore
    Bio-Rad Laboratories
    Enzo Biochem
    EKF Diagnostics
    Meso Scale Diagnostics, LLC.

    Market segment by Type, the product can be split into
    Safety biomarker
    Efficacy biomarker
    Validation biomarker
    Market segment by Application, split into
    Diagnostics development
    Drug discovery & development
    Personalized medicine
    Disease risk assessment
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Targeted Biomarker status, future forecast, growth opportunity, key market and key players.
    To present the Targeted Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Targeted Biomarker are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now